Consolidated Statement of Comprehensive Income

Profit after tax

–60.5

–86.8

114.6

254.7

Available-for-sale financial assets

Fair value adjustments

0.1

4.1

0.1

29.3

Reclassification to income statement

–

–22.8

–

–27.2

Deferred taxes

–

–0.2

–

0.6

Changes recognized in equity

0.1

–18.9

0.1

2.7

Derivative financial instruments

Fair value adjustments

–76.6

1.4

–51.0

13.2

Reclassification to income statement

12.3

–5.7

54.3

–3.6

Deferred taxes

11.3

0.4

1.2

–0.2

Changes recognized in equity

–53.0

–3.9

4.5

9.4

Remeasurement of the net defined benefit liability

Changes in remeasurement

–9.8

0.1

–9.8

2.0

Deferred taxes

–1.9

0.3

–1.9

0.1

Changes recognized in equity

–11.7

0.4

–11.7

2.1

Exchange differences on translating foreign operations

Changes taken directly to equity

61.4

26.7

42.0

–42.4

Reclassification to income statement

–

–

–

3.5

Changes recognized in equity

61.4

26.7

42.0

–38.9

Gains/losses recognized immediately in equity

–3.2

4.3

34.9

–24.7

Comprehensive income

–63.8

–82.5

149.5

230.0

of which attributable to Merck KGaA shareholders

–65.5

–83.5

145.5

228.2

of which attributable to non-controlling interest

1.7

1.0

4.0

1.8